To order this detailed 800+ page report, please visit this link
Key Inclusions
§ An overview of thecurrent market landscape of companies engaged in manufacturing prefilledsyringes, providing information on year of establishment, company size,geographical location of the headquarters and manufacturing facilities, type ofmaterial used (glass and plastic), number of barrel chambers (single chamberand dual chamber), type of needle system (fixed needle system, luer lock andluer cone) and syringe volume.
§ An overview of thecurrent market landscape of companies that are developing drugs in combinationwith prefilled syringes, featuring information on year of establishment,company size, geographical location of the developers, target therapeutic area,phases of development, type of drug molecule, route of administration, approvalyear (for marketed products), dosage details (for marketed products) and otherapproved dosage forms (for marketed products).
§ A detailedcompetitiveness analysis of the various prefilled syringes that we came across,taking into consideration the supplier power (based on the employee size ofdeveloper / manufacturer and their respective annual revenues) and key productspecifications, such as number of chambers in the barrel, number of needlesystems, volume of the barrel, technological advancement / user-friendlinessand other distinguishing features.
§ A list of marketeddrugs / therapies and pipeline candidates that are likely to be developed incombination with prefilled syringes in the near future, shortlisted based on anin-depth analysis that takes into consideration various relevant parameters,such as route of administration, type of drug molecule, target indications,other available dosage forms (for approved drugs) and historical annual salesinformation (for approved drugs).
§ An analysispresenting potential strategic partners (primarily drug developers) forprefilled syringe manufacturers (with regard to likely collaborationopportunities for combination product development) based on differentparameters, such as pipeline strength, target therapeutic indication(s) anddeveloper strength.
§ An analysis of thevarious prefilled syringe combination product-related initiatives of big pharmaplayers, based on parameters, such as current adoption (based on number ofapproved and under development prefilled syringe combination products) andlikely future adoption (based on potential injectable product candidates in thepipeline that are likely to be delivered via prefilled syringes), targettherapeutic area(s) and type of drug molecule.
§ A review of thelandscape of contract fill / finish services providers that offer services forprefilled syringes, featuring a list of active (large-sized) service providersand analysis based on a number of relevant parameters, such as year ofestablishment, company size, scale of operation (preclinical, clinical andcommercial), type of drug molecule (biologics and small molecules), and geographicallocation of the service provider.
§ A detailed discussionon various safety features (add-on and integrated devices) installed in recentversions of prefilled syringes and the companies involved in developing andmanufacturing such solutions.
§ An informativesummary of various guidelines established and issued by major regulatory bodiesfor the approval of prefilled syringes, across different countries /geographical regions.
§ Brief discussions ofcurrently available specialty syringes, which include prefilled flush syringes,prefilled diluent syringe systems and prefilled contrast agent deliverysystems.
§ A case study oncompanies that are engaged in the manufacturing of autoinjectors, featuringbrief profiles of key players in this domain; each profile includes an overviewof the firm, and information on its respective product portfolio.
§ Elaborate profiles ofprominent prefilled syringe manufacturers engaged in this domain, featuring abrief overview of the company, its financial information (if available),information on product portfolio, recent developments and an informed futureoutlook.
The report also features the likelydistribution of the current and forecasted opportunity across important marketsegments, mentioned below:
- Target therapeutic area
§ Autoimmune disorders
§ Infectious diseases
§ Neurological disorders
§ Blood disorders
§ Oncological disorders
§ Psychiatric disorders
§ Respiratory disorders
§ Cardiovascular disorders
§ Metabolic disorders
§ Ophthalmic diseases
§ Orthopedic disorders
§ Others
- Type of syringe
§ Specialty syringes
- Type of syringe barrel material
§ Glass
§ Plastic
- Number of barrel chambers
§ Single chamber
§ Dual chamber
- Key geographical regions
§ North America
§ Europe
§ Latin America
§ Asia Pacific
§ Middle East and Africa
To request sample pages, please visit this link
Key Questions Answered
§ Who are the key players engaged in the manufacturing ofprefilled syringes, across the globe?
§ What are the prevalent trends within the prefilled syringesmarket?
§ Whatare the current regulatory requirements for securing marketing authorizations forprefilled syringe combination products, across different countries?
§ What technological advances have taken place in theprefilled syringes market?
§ Whatare the key growth drivers within the prefilled syringes market?
§ Who are the key contract service providers in this domain?
§ How is the current and future market opportunity likely tobe distributed across key market segments?
You may also be interested in the following titles:
1. Global AutoinjectorsMarket (3rd Edition), 2020-2030
2. Novel VaccineDelivery Devices Market, 2019-2030
4. Medical Device Labels Manufacturing Market, 2019 - 2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
